Dr. Cynthia Miller on Lp(a) Screening and Preventing Cardiovascular Disease

The introduction of statins revolutionized the prevention of cardiovascular disease, but some patients don’t respond, particularly those with a lesser-known type of lipid disease called elevated lipoprotein(a) (Lp[a]). Fortunately, clinical trials of new medications capable of lowering Lp(a) are showing promise. Some cardiologists have started evaluating their patients for Lp(a), but others opt to wait until statins are unsuccessful instead of taking a preventive approach.

DocWire News spoke with Cynthia Miller, MD, MPH, FACP, vice president and medical director of PRECISIONvalue, about the importance of early Lp(a) screening.